Implementation of the Quantitative SWOT Analysis Method in the Research on the Contemporary State and Prospects of Consistent Development of the Pharmaceutical Branch
*Corresponding Author E-mail: email@example.com
The aim of the current paper is the research on the contemporary state of the pharmaceutical branch in Ukraine and determination of strategic directions of its consistent development using the quantitative SWOT analysis method.
The current paper depicts the research on the contemporary state and revealing of prospects and possible strategic directions of the consistent development of the pharmaceutical branch in Ukraine using the SWOT analysis, taken on a quantitative basis. SWOT analysis was conducted in several stages: revealing and selection of the most prominent factors of the internal and external environment of Ukrainian pharmacy; polling pharmacy specialists as to the level of impact of the factors on the development of the branch using questionnaires; creation of the interrelation diagram of elements of the pharmaceutical branch internal environment; quantitative calculation of the factors’ impact and revealing the key ones; construction of SWOT matrix and the vector of the development direction of Ukrainian pharmacy. The strengths of the internal environment were found to substantially prevail over the weaknesses, while the threats of the external environment though insignificantly but exceed the capabilities of the pharmaceutical branch. In general, despite all the unfavorable circumstances, Ukrainian pharmacy has a powerful inner potential for the further development and resistance to threats. In this case, the concentrated growth strategy is recommended.
Proceeding from the SWOT analysis carried out, the principal strategic directions of the consistent development of the pharmaceutical branch are related to the powerful pharmaceutical industry. The top-priority ones are: the capacity increase of medicinal products production, expansion of nomenclature of medicinal products by domestic production, new substances development, creation of import-substituting pharmaceutical and biotechnological manufacturing facilities, etc.
Pharmaceutical branch, pharmaceutical enterprises, medicinal products, sustainable development, SWOT analysis, strategy.